“Evaluation model of the effect of Rofecoxib on the co-prescription of gastroprotective agents observed during the treatment of ostheoarthritis”, Reumatismo, vol. 54, no. 4, pp. 331–339, Dec. 2002, doi: 10.4081/reumatismo.2002.331.